Back to results

Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism

Primary Purpose

Hyperparathyroidism

Status

Unknown status

Phase

Phase 1

Locations

Canada

Study Type

Interventional

Intervention

Far Infrared Radiation

About this trial

This is an interventional treatment trial for Hyperparathyroidism focused on measuring PRIMARY HYPERPARATHYROIDISM, PARATHYROID NEOPLASMS, SECONDARY HYPERPARATHYROIDISM, HYPOCALCEMIA

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Persons with parathyroid disease

Exclusion Criteria:

None

Sites / Locations

The Centre for Incurable Diseases

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Arm Description

Outcomes

Primary Outcome Measures

The primary end point is to determine the therapeutic effects of far infrared radiation on Hyperparathyroidism.

Secondary Outcome Measures

Effect of far infrared radiation treatment on other immune deficiency diseases like thyroidism and diabetes

Full Information

NCT ID

NCT00573573

First Posted

December 12, 2007

Last Updated

March 23, 2009

Sponsor

GAAD Medical Research Institute Inc.

1. Study Identification

Unique Protocol Identification Number

NCT00573573

Brief Title

Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism

Official Title

Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism.

Study Type

Interventional

2. Study Status

Record Verification Date

March 2009

Overall Recruitment Status

Unknown status

Study Start Date

January 2007 (undefined)

Primary Completion Date

March 2009 (Anticipated)

Study Completion Date

July 2009 (Anticipated)

3. Sponsor/Collaborators

Name of the Sponsor

GAAD Medical Research Institute Inc.

4. Oversight

Data Monitoring Committee

Yes

5. Study Description

Brief Summary

A study to determine the possibility of using far infrared radiation to treat Hyperparathyroidism.

Detailed Description

Overactive parathyroid glands secrete an excess of parathyroid hormones, resulting in increased levels of calcium in the blood stream, which can lead to weakening of the bones and to kidney stones. We are postulating that the non-invasive energy specific electromagnetic radiation of the central nervous system, the viscera and the endocrine system has the potential to stop the over secretion of the parathyroid hormones and normalize the body's metabolic functions.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study

Hyperparathyroidism

Keywords

PRIMARY HYPERPARATHYROIDISM, PARATHYROID NEOPLASMS, SECONDARY HYPERPARATHYROIDISM, HYPOCALCEMIA

7. Study Design

Primary Purpose

Treatment

Study Phase

Phase 1

Interventional Study Model

Single Group Assignment

Masking

None (Open Label)

Allocation

Non-Randomized

Enrollment

2 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title

Arm Type

Other

Intervention Type

Radiation

Intervention Name(s)

Far Infrared Radiation

Intervention Description

Far Infrared Radiation (5μm to 20μm wavelength) for 30 to 40 minutes each session.

Primary Outcome Measure Information:

Title

The primary end point is to determine the therapeutic effects of far infrared radiation on Hyperparathyroidism.

Time Frame

2 years

Secondary Outcome Measure Information:

Title

Effect of far infrared radiation treatment on other immune deficiency diseases like thyroidism and diabetes

Time Frame

2 years

10. Eligibility

Sex

All

Accepts Healthy Volunteers

Eligibility Criteria

Inclusion Criteria: Persons with parathyroid disease Exclusion Criteria: None

Overall Study Officials:

First Name & Middle Initial & Last Name & Degree

Ken Nedd, M.D.

Organizational Affiliation

GAAD Medical Research Institute Inc.

Official's Role

Study Director

First Name & Middle Initial & Last Name & Degree

Kwasi Donyina, Ph.D.

Organizational Affiliation

GAAD Medical Research Institute Inc.

Official's Role

Study Chair

Facility Information:

Facility Name

The Centre for Incurable Diseases

City

Toronto

State/Province

Ontario

ZIP/Postal Code

M4V 1L5

Country

Canada

12. IPD Sharing Statement

Learn more about this trial

Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism

We'll reach out to this number within 24 hrs